Ignite Planners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
2,057
-305
-13% -$41.2K 0.04% 329
2026
Q1
$302K Buy
2,362
+15
+0.6% +$1.87K 0.05% 321
2025
Q4
$293K Buy
+2,347
New +$269K 0.04% 327
2024
Q4
Sell
-2,408
Closed -$238K 321
2024
Q3
$238K Buy
+2,408
New +$237K 0.05% 264
2024
Q2
Sell
-2,635
Closed -$247K 306
2024
Q1
$247K Buy
+2,635
New +$245K 0.07% 243

Other funds holding XBI

Ignite Planners's XBI Position: Q2 2026 in Review

Ignite Planners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q2 2026, selling an estimated $41.2K and leaving 2,057 shares worth $326K. The position accounts for 0.04% of the portfolio, ranked #329.

Ignite Planners first reported a position in XBI in Q1 2024 and has held it in 5 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Ignite Planners held 2,057 shares of State Street SPDR S&P Biotech ETF worth $326K as of Q2 2026.
  • Ignite Planners sold 305 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $41.2K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Ignite Planners's portfolio in Q2 2026, its #329 holding.
  • Ignite Planners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 5 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.